In this free webinar, gain insights into the structural design difficulties and research progress of bispecific antibodies. Attendees will learn the key considerations of bispecific antibody structural design and analysis of general design strategies. The featured speaker will discuss production strategies and by-product purification plans for bispecific antibodies with different structures.
TORONTO, Nov. 22, 2023 /PRNewswire-PRWeb/ -- Discover this groundbreaking webinar delving into the strategic approaches of bispecific antibody (BsAb) design, production and purification. BsAbs have become increasingly of interest by enabling new therapeutic applications for a variety of indications, including cancer, chronic inflammatory diseases, autoimmunity, neurodegeneration, bleeding disorders and infections. Currently, there are 12 bispecific antibodies approved worldwide.
Natural antibodies are monospecific, while BsAbs recognize two different epitopes or antigens. This makes BsAbs hold great therapeutic promise for many diseases by linking an effector to a target cell, acting as ligands to two receptors or other mechanisms. However, the translation of these concepts into treatments is challenging. Without proper engineering, the side products from the light chain mispairing, heavy chain mispairing and BsAb fragments could lead to low purity, inability of repetition and toxicity.
To solve the technical problems, advanced design strategies have been investigated, such as Knobs-into-holes, CrossMab technology, Duobody and common light chain. These technologies have greatly improved the development of bispecific antibodies, with many entities employing similar design approaches to develop their BsAb therapeutics.
Do BsAb designs always work well as reported? What considerations should be taken for BsAb design?
GenScript has production experience on thousands of BsAbs including about 80 BsAb formats and know well how the design affects the production.
This webinar will focus on various strategies for BsAb design, the side products and how to get high purity BsAbs with different purification columns.
Join this webinar to gain insights into the diverse applications, design considerations and production strategies of bispecific antibodies.
Join Xiaoyu Chen, Protein Senior Scientist, GenScript, for the live webinar on Friday, December 8, 2023, at 10am EST (4pm CET/EU-Central).
For more information, or to register for this event, visit Bispecific Antibodies: Structural Design, Production and Purification Strategies.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article